PTCH2
| Patched 2 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||||
| Symbols | PTCH2 ; PTC2 | ||||||||||||
| External IDs | OMIM: 603673 HomoloGene: 37842 GeneCards: PTCH2 Gene | ||||||||||||
| |||||||||||||
| Orthologs | |||||||||||||
| Species | Human | Mouse | |||||||||||
| Entrez | 8643 | 19207 | |||||||||||
| Ensembl | ENSG00000117425 | ENSMUSG00000028681 | |||||||||||
| UniProt | Q9Y6C5 | O35595 | |||||||||||
| RefSeq (mRNA) | NM_001166292 | NM_008958 | |||||||||||
| RefSeq (protein) | NP_001159764 | NP_032984 | |||||||||||
| Location (UCSC) |
Chr 1: 44.82 – 44.84 Mb |
Chr 4: 117.1 – 117.12 Mb | |||||||||||
| PubMed search | |||||||||||||
Patched 2 is a protein that in humans is encoded by the PTCH2 gene.[1]
Function
This gene encodes a transmembrane receptor of the patched gene family. The encoded protein may function as a tumor suppressor in the hedgehog signaling pathway.[1]
Clinical significance
Alterations in this gene have been associated with nevoid basal cell carcinoma syndrome, basal cell carcinoma, medulloblastoma, and susceptibility to congenital macrostomia.[1]
References
Further Reading
- Fujii K, Ohashi H, Suzuki M, Hatsuse H, Shiohama T, Uchikawa H, Miyashita T (2013). "Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome". Familial Cancer 12 (4): 611–4. doi:10.1007/s10689-013-9623-1. PMID 23479190.
- Smyth I, Narang MA, Evans T, Heimann C, Nakamura Y, Chenevix-Trench G, Pietsch T, Wicking C, Wainwright BJ (1999). "Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32". Human Molecular Genetics 8 (2): 291–7. doi:10.1093/hmg/8.2.291. PMID 9931336.
- Zaphiropoulos PG, Undén AB, Rahnama F, Hollingsworth RE, Toftgård R (1999). "PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas". Cancer Research 59 (4): 787–92. PMID 10029063.
- Rahnama F, Toftgård R, Zaphiropoulos PG (2004). "Distinct roles of PTCH2 splice variants in Hedgehog signalling". Biochemical Journal 378 (Pt 2): 325–34. doi:10.1042/BJ20031200. PMC 1223965. PMID 14613484.
- "Nevoid Basal Cell Carcinoma Syndrome". 1993. PMID 20301330.
- Li TJ, Sun LS, Luo HY, Yuan JW, Gao L, Gu XM, Li XF, Xu LL (2009). "Studies on keratocystic odontogenic tumors". Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 41 (1): 16–20. PMID 19221557.
- Fan Z, Du J, Liu H, Zhang H, Dlugosz AA, Wang CY, Fan M, Shen Y, Wang S (2009). "A susceptibility locus on 1p32-1p34 for congenital macrostomia in a Chinese family and identification of a novel PTCH2 mutation". American Journal of Medical Genetics Part A 149A (3): 521–4. doi:10.1002/ajmg.a.32647. PMID 19208383.
- Carpenter D, Stone DM, Brush J, Ryan A, Armanini M, Frantz G, Rosenthal A, de Sauvage FJ (1998). "Characterization of two patched receptors for the vertebrate hedgehog protein family". Proceedings of the National Academy of Sciences of the United States of America 95 (23): 13630–4. doi:10.1073/pnas.95.23.13630. PMC 24870. PMID 9811851.
- Villavicencio EH, Walterhouse DO, Iannaccone PM (2000). "The sonic hedgehog-patched-gli pathway in human development and disease". The American Journal of Human Genetics 67 (5): 1047–54. doi:10.1016/S0002-9297(07)62934-6. PMC 1288546. PMID 11001584.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
This article is issued from Wikipedia - version of the Saturday, November 15, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.